Access Statistics for Toshiaki Iizuka

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are Quality-Adjusted Medical Prices Declining for Chronic Disease? Evidence from Diabetes Care in Four Health Systems 0 0 0 55 0 1 2 48
Asymmetric Demand Response when Prices Increase and Decrease: The Case of Child Healthcare 0 0 1 17 0 0 5 46
Asymmetric Demand Response when Prices Increase and Decrease: The Case of Child Healthcare 0 0 0 10 2 4 6 43
Drug Advertising and Health Habit 0 0 0 70 1 1 2 416
False Alarm? Estimating the Marginal Value of Health Signals 0 0 0 49 1 2 3 60
Free for Children? Patient Cost-sharing and Healthcare Utilization 0 0 0 18 1 4 14 108
Free for Children? Patient Cost-sharing and Healthcare Utilization 0 0 0 27 0 2 5 56
Is Zero a Special Price? Evidence from Child Healthcare 0 0 1 33 0 2 4 97
Long-term Care in Japan 0 0 2 20 2 4 10 34
Promoting Innovation in Small Markets: Evidence from the market for rare and intractable diseases 0 0 0 24 0 0 1 39
Robots and Labor in Nursing Homes 0 0 38 38 0 2 26 26
Robots and Labor in the Service Sector: Evidence from Nursing Homes 0 0 3 60 2 4 15 128
Total Working Papers 0 0 45 421 9 26 93 1,101

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An Empirical Analysis of Planned Obsolescence 0 1 4 74 3 4 11 252
Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems 0 0 0 1 3 3 4 28
Asymmetric Demand Response When Prices Increase and Decrease: The Case of Child Health Care 0 0 3 6 2 2 7 95
Cartel sustainability in retail markets: Evidence from a health service sector 0 0 0 19 0 1 3 118
Comment on “How does the Price Regulation Policy Impact on Patient–Nurse Ratios and the Length of Hospital Stays in Japanese Hospitals?” 0 0 0 1 0 0 0 20
Comment on “Sustainable Health Financing for COVID‐19 Preparedness and Response in Asia and the Pacific” 0 0 1 5 1 1 3 9
DIRECT TO CONSUMER ADVERTISING AND PRESCRIPTION CHOICE 1 1 1 79 2 2 2 237
DURABLE GOODS PRICE CYCLES: THEORY AND EVIDENCE FROM THE TEXTBOOK MARKET 0 0 0 9 0 0 4 66
Does Higher Malpractice Pressure Deter Medical Errors? 0 0 1 36 0 1 2 141
Effect of age-based left-digit bias on stroke diagnosis: Regression discontinuity design 0 0 0 1 0 0 1 6
Experts' agency problems: evidence from the prescription drug market in Japan 0 0 2 34 0 0 3 132
False alarm? Estimating the marginal value of health signals 0 0 1 6 4 6 13 65
GENERIC ENTRY IN A REGULATED PHARMACEUTICAL MARKET* 0 0 0 34 1 2 2 120
Is Zero a Special Price? Evidence from Child Health Care 0 1 3 12 2 6 14 45
Patient cost sharing and medical expenditures for the Elderly 1 1 1 24 1 2 3 122
Physician Agency and Adoption of Generic Pharmaceuticals 1 1 2 62 1 1 7 283
Promoting innovation in small markets: Evidence from the market for rare and intractable diseases 0 0 0 3 0 0 2 31
The Effect of Prescription Drug Advertising on Doctor Visits 1 1 1 81 1 3 6 323
The Impact of Physician Supply on the Healthcare System: Evidence from Japan's New Residency Program 0 0 2 12 0 0 5 39
The generic drug market in Japan: will it finally take off? 0 0 1 32 1 1 4 95
What Explains the Use of Direct‐to‐Consumer Advertising of Prescription Drugs? 0 1 1 119 0 1 3 430
Total Journal Articles 4 7 24 650 22 36 99 2,657

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Statistics updated 2025-11-08